tiprankstipranks
Trending News
More News >
Alkyl Amines Chemicals Limited (IN:ALKYLAMINE)
:ALKYLAMINE
India Market
Advertisement

Alkyl Amines Chemicals Limited (ALKYLAMINE) AI Stock Analysis

Compare
1 Followers

Top Page

IN:ALKYLAMINE

Alkyl Amines Chemicals Limited

(ALKYLAMINE)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
₹1,904.00
▲(7.06% Upside)
Alkyl Amines Chemicals Limited's strong financial performance is the primary driver of its overall score, reflecting robust profitability and financial stability. However, technical analysis indicates bearish momentum, and the stock appears overvalued based on its high P/E ratio and low dividend yield. These factors contribute to a moderate overall stock score.

Alkyl Amines Chemicals Limited (ALKYLAMINE) vs. iShares MSCI India ETF (INDA)

Alkyl Amines Chemicals Limited Business Overview & Revenue Model

Company DescriptionAlkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. It offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, dimethylaminopropylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. The company also provides special chemicals, such as acetonitrile, 1,8-diazabicyclo[5.4.0]undec-7-ene, alchan 100, alchan 300, 2-aminoethoxy ethanol, 2-ethoxy ethylamine, dimethylpropyleneurea, tetramethyl ethylenediamine, and monomethylamine. It serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. The company was incorporated in 1979 and is headquartered in Navi Mumbai, India.
How the Company Makes MoneyAlkyl Amines Chemicals Limited generates revenue primarily through the sale of its core products, which include aliphatic amines, specialty amines, and their derivatives. The company operates on a business-to-business (B2B) model, supplying these chemicals to a variety of sectors such as pharmaceuticals, agriculture, and personal care. Key revenue streams are driven by high demand for its products in the pharmaceutical industry for drug formulation and in agrochemicals for pest control formulations. Additionally, Alkyl Amines benefits from strategic partnerships with key players in these industries, ensuring a steady flow of orders and long-term contracts. Market dynamics, such as increasing demand for specialty chemicals and the expansion of its production capabilities, further contribute to its profitability.

Alkyl Amines Chemicals Limited Financial Statement Overview

Summary
Alkyl Amines Chemicals Limited demonstrates strong financial health characterized by robust profitability, a solid balance sheet, and reliable cash flow generation. The company exhibits a positive growth trajectory in revenue and profitability, supported by low leverage and effective equity management. While operational efficiency and cash flow variability present risks, the overall financial position remains strong.
Income Statement
82
Very Positive
The company shows strong profitability with a consistent increase in gross profit and net profit margins over time. The revenue growth rate from 2024 to 2025 is notable, indicating a positive trajectory. However, the EBIT and EBITDA margins have shown fluctuations, indicating potential volatility in operational efficiency.
Balance Sheet
85
Very Positive
The balance sheet is robust with a low debt-to-equity ratio, indicating low leverage and financial stability. The return on equity is healthy, reflecting effective use of shareholder funds. The equity ratio is strong, highlighting a solid asset base funded by equity.
Cash Flow
78
Positive
Operating cash flow remains strong and consistently aligns well with net income, indicating quality earnings. Free cash flow has improved significantly in recent years, showcasing better capital management. However, historical fluctuations in free cash flow growth rates signal potential variability in cash flow generation.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue15.78B15.72B14.41B16.83B15.42B12.42B
Gross Profit7.12B7.14B6.54B8.04B6.92B7.08B
EBITDA2.91B2.97B2.54B3.48B3.26B4.30B
Net Income1.87B1.86B1.49B2.29B2.25B2.95B
Balance Sheet
Total Assets0.0017.89B15.84B15.90B13.71B11.45B
Cash, Cash Equivalents and Short-Term Investments2.03B2.03B303.92M171.95M615.33M1.55B
Total Debt0.0055.20M31.68M877.50M232.89M470.77M
Total Liabilities-14.02B3.86B3.16B4.21B3.82B3.53B
Stockholders Equity14.02B14.02B12.67B11.69B9.90B7.92B
Cash Flow
Free Cash Flow0.002.15B1.53B-550.40M-422.81M2.08B
Operating Cash Flow0.002.63B2.75B2.48B2.05B3.64B
Investing Cash Flow0.00-1.96B-1.21B-2.77B-2.06B-2.13B
Financing Cash Flow0.00-491.50M-1.40B80.00M-572.89M-864.51M

Alkyl Amines Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1778.45
Price Trends
50DMA
1955.61
Negative
100DMA
2078.74
Negative
200DMA
1910.33
Negative
Market Momentum
MACD
-36.38
Positive
RSI
31.16
Neutral
STOCH
10.56
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALKYLAMINE, the sentiment is Negative. The current price of 1778.45 is below the 20-day moving average (MA) of 1871.13, below the 50-day MA of 1955.61, and below the 200-day MA of 1910.33, indicating a bearish trend. The MACD of -36.38 indicates Positive momentum. The RSI at 31.16 is Neutral, neither overbought nor oversold. The STOCH value of 10.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALKYLAMINE.

Alkyl Amines Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
₹72.90B12.973.67%-9.97%9.63%
68
Neutral
₹74.48B11.592.67%3.26%19.18%
65
Neutral
₹45.54B29.910.77%-12.28%-22.10%
62
Neutral
₹84.27B29.460.89%-8.23%69.99%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹93.53B51.340.56%3.95%8.28%
56
Neutral
₹50.89B28.921.01%0.91%18.12%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,778.45
-230.00
-11.45%
IN:BALAMINES
Balaji Amines Limited
1,400.00
-643.42
-31.49%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
489.90
-96.30
-16.43%
IN:GSFC
Gujarat State Fertilizers & Chemicals Limited
186.90
-12.00
-6.03%
IN:RALLIS
Rallis India Limited
248.20
-72.64
-22.64%
IN:RCF
Rashtriya Chemicals & Fertilizers Ltd.
148.85
-11.79
-7.34%

Alkyl Amines Chemicals Limited Corporate Events

Alkyl Amines Announces Special Window for Share Transfer Requests
Nov 1, 2025

Alkyl Amines Chemicals Limited announced a special window for physical shareholders to re-lodge transfer requests of physical shares. This move, in compliance with a SEBI circular, aims to streamline share transfer processes and ensure regulatory adherence, potentially impacting shareholder engagement and operational efficiency.

Alkyl Amines Confirms Compliance with SEBI Regulations for Q3 2025
Oct 7, 2025

Alkyl Amines Chemicals Limited has confirmed the dematerialization of securities for the quarter ending September 30, 2025, in compliance with Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018. This announcement ensures transparency and regulatory compliance, reinforcing the company’s commitment to adhering to market standards and maintaining stakeholder trust.

Alkyl Amines Launches ‘Saksham Niveshak’ to Aid Shareholders
Oct 4, 2025

Alkyl Amines Chemicals Limited has launched a ‘100 Days Campaign’ called ‘Saksham Niveshak’ to assist shareholders in claiming unpaid or unclaimed dividends. This initiative, requested by the Investor Education and Protection Fund Authority, aims to enhance shareholder engagement by providing detailed information and facilitating the claims process, thereby preventing the transfer of unclaimed dividends to the IEPFA.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 07, 2025